| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $18.1M | +234.4% |
| Cost of Revenue | $3.4M | +130.3% |
| R&D Expense | $31.3M | -47.7% |
| SG&A Expense | $20.7M | -5.1% |
| Operating Income | -$37.4M | +54.4% |
| Income Tax | $28K | +114.3% |
| Net Income | -$41.7M | +50.6% |
| EPS (Basic) | -$4.43 | — |
| EPS (Diluted) | -$4.43 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $13.2M | -75.9% |
| Inventory | $20K | -47.4% |
| Current Assets | $16.4M | -73.5% |
| Total Assets | $33.4M | -58.4% |
| Current Liabilities | $22.1M | +11.2% |
| Total Liabilities | $44.3M | -22.5% |
| Stockholders' Equity | -$10.9M | -147.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$26.8M | +62.3% |
| Capital Expenditures | $95K | -15.9% |
| Investing Cash Flow | -$95K | +15.9% |
| Financing Cash Flow | -$14.7M | -113.8% |
| Free Cash Flow | -$26.8M | +62.2% |
| — |